Trials / Unknown
UnknownNCT06086470
Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease
A Prospective Single-Center, Open Label, Non-Randomized Study Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Qidni Labs Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this clinical study is to evaluate the safety of the Qidni/D Hemodialysis System in patients with end-stage renal disease. The main question it aims to answer is: Is the Qidni/D safe for performing hemodialysis? Participants will be subjected to one treatment of hemodialysis for up to 4 hours with the use of the Qidni/D.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Qidni/D Hemodialysis System | Qidni/D is a hemodialysis device for patients with end-stage renal disease. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-07-14
- Completion
- 2024-07-14
- First posted
- 2023-10-17
- Last updated
- 2023-10-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06086470. Inclusion in this directory is not an endorsement.